A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms.
作者信息
Bueno Maria J, Colomer Ramon
机构信息
Breast Cancer Clinical Research Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Breast Cancer Clinical Research Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain; Medical Oncology Division, Hospital Universitario La Princesa, Madrid, Spain.
出版信息
EBioMedicine. 2015 Aug;2(8):778-779. doi: 10.1016/j.ebiom.2015.08.023. Epub 2015 Aug 14.
Abstract
摘要
相似文献
1
A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms.一种脂肪酸合酶抑制剂展现出新的抗癌机制。
EBioMedicine. 2015 Aug;2(8):778-779. doi: 10.1016/j.ebiom.2015.08.023. Epub 2015 Aug 14.
2
Recent Advances in the Development of Fatty Acid Synthase Inhibitors as Anticancer Agents.脂肪酸合成酶抑制剂作为抗癌剂的研究进展。
Mini Rev Med Chem. 2020;20(18):1820-1837. doi: 10.2174/1389557520666200811100845.
3
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity.奥利司他是一种具有抗肿瘤活性的新型脂肪酸合酶抑制剂。
Cancer Res. 2004 Mar 15;64(6):2070-5. doi: 10.1158/0008-5472.can-03-3645.
4
Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.表没食子儿茶素-3-没食子酸酯是完整细胞中脂肪酸合酶的有效天然抑制剂，并能选择性地诱导前列腺癌细胞凋亡。
Int J Cancer. 2003 Oct 10;106(6):856-62. doi: 10.1002/ijc.11317.
5
(-)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects.（-）-UB006：一种新型脂肪酸合酶抑制剂及细胞毒性剂，无厌食副作用。
Eur J Med Chem. 2017 May 5;131:207-221. doi: 10.1016/j.ejmech.2017.03.012. Epub 2017 Mar 12.
6
Fatty Acid Synthase: An Emerging Target in Cancer.脂肪酸合酶：癌症治疗的新兴靶点。
Molecules. 2020 Aug 28;25(17):3935. doi: 10.3390/molecules25173935.
7
Fatty acid synthase inhibitors: new directions for oncology.脂肪酸合酶抑制剂：肿瘤学的新方向
Expert Opin Investig Drugs. 2007 Nov;16(11):1817-29. doi: 10.1517/13543784.16.11.1817.
8
Obesity. Enzyme blocker prompts mice to shed weight.肥胖。酶阻断剂促使小鼠减重。
Science. 2000 Jun 30;288(5475):2299-300. doi: 10.1126/science.288.5475.2299a.
9
[Fatty acid synthase: a new anti-tumor target].[脂肪酸合酶：一种新的抗肿瘤靶点]
Med Clin (Barc). 2009 Mar 14;132(9):359-63. doi: 10.1016/j.medcli.2008.07.022. Epub 2009 Mar 9.
10
Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.脂肪酸合酶抑制剂奥利司他对T细胞淋巴瘤的肿瘤生长抑制及化疗增敏作用：重构肿瘤微环境和多药耐药表型的影响
Biochim Biophys Acta. 2014 Jan;1840(1):294-302. doi: 10.1016/j.bbagen.2013.09.020. Epub 2013 Sep 20.
引用本文的文献
1
Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer.鉴定新型选择性CD36抑制剂以增强HER2阳性乳腺癌的HER2靶向治疗效果。
Sci Rep. 2025 Aug 6;15(1):28709. doi: 10.1038/s41598-025-14639-z.
2
Functional Role of Resveratrol in Inducing Apoptosis in Breast Cancer Subtypes via Inhibition of Intracellular Fatty Acid Synthase.白藜芦醇通过抑制细胞内脂肪酸合酶诱导乳腺癌亚型细胞凋亡的功能作用
Molecules. 2025 Jul 8;30(14):2891. doi: 10.3390/molecules30142891.
3
4-1BBL Regulates the Polarization of Macrophages, and Inhibition of 4-1BBL Signaling Alleviates Imiquimod-Induced Psoriasis.4-1BBL 调节巨噬细胞极化，抑制 4-1BBL 信号通路可缓解咪喹莫特诱导的银屑病。
J Immunol. 2020 Apr 1;204(7):1892-1903. doi: 10.4049/jimmunol.1900983. Epub 2020 Feb 10.
4
Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.新型脂肪酸合酶抑制剂在原发性结肠癌细胞及患者来源的结肠癌异种移植模型中的临床前评估
Oncotarget. 2018 May 15;9(37):24787-24800. doi: 10.18632/oncotarget.25361.
5
Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression.探究前列腺肿瘤微环境I：葡萄糖剥夺对前列腺癌进展细胞模型的影响
Oncotarget. 2017 Feb 28;8(9):14374-14394. doi: 10.18632/oncotarget.14605.
本文引用的文献
1
Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression.脂肪酸合酶抑制从头合成棕榈酸可通过重塑细胞膜、抑制信号通路和重编程基因表达诱导肿瘤细胞凋亡。
EBioMedicine. 2015 Jul 2;2(8):808-24. doi: 10.1016/j.ebiom.2015.06.020. eCollection 2015 Aug.
2
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.一种新型脂肪酸合酶抑制剂对 HER2+乳腺癌异种移植瘤具有活性，并对抗 HER2 耐药细胞系具有活性。
Breast Cancer Res. 2011;13(6):R131. doi: 10.1186/bcr3077. Epub 2011 Dec 16.
3
Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity.具有抗癌活性的新型脂肪酸合酶抑制剂
Clin Cancer Res. 2009 Dec 15;15(24):7608-7615. doi: 10.1158/1078-0432.CCR-09-0856.
4
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome.脂肪酸合酶与小窝蛋白-1在胰腺导管腺癌中的共表达：对肿瘤进展及临床结局的影响
Cell Cycle. 2008 Oct;7(19):3021-5. doi: 10.4161/cc.7.19.6719. Epub 2008 Oct 23.
5
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.脂肪酸合酶与癌症发病机制中的脂肪生成表型
Nat Rev Cancer. 2007 Oct;7(10):763-77. doi: 10.1038/nrc2222.
6
7
Architecture of mammalian fatty acid synthase at 4.5 A resolution.分辨率为4.5埃的哺乳动物脂肪酸合酶结构
Science. 2006 Mar 3;311(5765):1258-62. doi: 10.1126/science.1123248.
8
Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells.表没食子儿茶素-3-没食子酸酯是完整细胞中脂肪酸合酶的有效天然抑制剂，并能选择性地诱导前列腺癌细胞凋亡。
Int J Cancer. 2003 Oct 10;106(6):856-62. doi: 10.1002/ijc.11317.
9
10
Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription.脂肪合成中酶的营养与激素调节：脂肪酸合酶及线粒体甘油-3-磷酸酰基转移酶基因转录的研究
Annu Rev Nutr. 1998;18:331-51. doi: 10.1146/annurev.nutr.18.1.331.
Zotero 插件